pentobarbital will reduce the extent or impact of buprenorphine buccal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital will decrease the extent or effect of repaglinide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will lower the extent or result of abiraterone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will decrease the extent or result of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
Keep track of Closely (one)pentobarbital will reduce the level or result of osilodrostat by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lower the extent or outcome of iloperidone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
Monoamine oxidase inhibitors (MAOI) might inhibit barbiturate metabolism and lengthen barbiturate effects; keep an eye on closely
Reserve concomitant prescribing of such drugs in clients for whom other cure solutions are insufficient. Limit dosages and durations for the least necessary. Monitor carefully for signs of respiratory depression and sedation.
pentobarbital will reduce the extent or impact of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Closely. Look at a rise in cannabidiol dosage (dependant on medical response and tolerability) when coadministered with a powerful CYP3A4 inducer.
buprenorphine transdermal and pentobarbital the two raise sedation. Stay clear of or Use Alternate Drug. Restrict use to patients for whom substitute procedure options are inadequate
fentanyl transdermal and pentobarbital both enhance sedation. Avoid or Use Alternate Drug. Restrict use to people for whom alternate procedure solutions are insufficient
pentobarbital will lessen the level or impact of buprenorphine, extensive-performing injection by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor read more Carefully. People who transfer to buprenorphine lengthy-acting injection from transmucosal buprenorphine coadministered with CYP3A4 inducers need to be monitored to ensure buprenorphine plasma levels are enough.
pentobarbital will decrease the extent or result of diazepam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will lessen the level or result of paclitaxel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unfamiliar.